Clinical Trial Update: Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating deslorelin with low-dose add-back estradiol and testosterone to prevent breast cancer in premenopausal women at high hereditary risk (B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Deslorelin (deslorelin)
• ESTRADIOL (Estradiol)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: City of Hope Medical Center | Conditions: brca1 Mutation Carrier, brca2 Mutation Carrier | Phase 2 | Status: ACTIVE_NOT_RECRUITING